endometrial cancer

Paclitaxel, Carboplatin, and Bevacizumab in Advanced and Recurrent Endometrial Carcinoma
Peter G. Rose, Shamshad Ali, Mehdi Moslemi-Kebria, Fiona Simpkins

International Journal of Gynecologic Cancer Mar 2017, 27 (3) 452-458; DOI: 10.1097/IGC.0000000000000891
Aberrant MicroRNA Expression in Patients With Endometrial Cancer
Martina Montagnana, Marco Benati, Elisa Danese, Silvia Giudici, Melissa Perfranceschi, Orazio Ruzzenenete, Gian Luca Salvagno, Antonella Bassi, Matteo Gelati, Elisa Paviati, Gian Cesare Guidi, Massimo Franchi, Giuseppe Lippi

International Journal of Gynecologic Cancer Mar 2017, 27 (3) 459-466; DOI: 10.1097/IGC.0000000000000913
Expression of PTEN and β-Catenin and Their Relationship With Clinicopathological and Prognostic Factors in Endometrioid Type Endometrial Cancer
Veysel Sal, Fuat Demirkiran, Hakan Erenel, Nedim Tokgozoglu, Ilker Kahramanoglu, Tugan Bese, Hasan Turan, Nigar Sofiyeva, Zerrin Calay, Macit Arvas, Onur Guralp

International Journal of Gynecologic Cancer Mar 2016, 26 (3) 512-520; DOI: 10.1097/IGC.0000000000000626
Tubal Ligation and Risk of Endometrial Cancer: Findings From the Women’s Health Initiative
Ira Winer, Amy Lehman, Jean Wactawski-Wende, Randal Robinson, Michael Simon, Michele Cote

International Journal of Gynecologic Cancer Mar 2016, 26 (3) 464-471; DOI: 10.1097/IGC.0000000000000651
Exploring Morphologic and Molecular Aspects of Endometrial Cancer Under Progesterone Treatment in the Context of Fertility Preservation
Mignon D.J.M. van Gent, Alina R. Nicolae-Cristea, Cor D. de Kroon, Elisabeth M. Osse, Marjolein J. Kagie, J. Baptist M.Z. Trimbos, Hans Marten Hazelbag, Vincent T.H.B.M. Smit, Tjalling Bosse

International Journal of Gynecologic Cancer Mar 2016, 26 (3) 483-490; DOI: 10.1097/IGC.0000000000000629
Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence
Christopher Hall, Rebecca L. Stone, Ashita Gehlot, Kristin K. Zorn, Alexander F. Burnett

International Journal of Gynecologic Cancer Feb 2016, 26 (2) 313-317; DOI: 10.1097/IGC.0000000000000603
Endometrial Cancer Survivors’ Perceptions of Provider Obesity Counseling and Attempted Behavior Change: Are We Seizing the Moment?
Leslie H. Clark, Emily M. Ko, Amber Kernodle, Ariel Harris, Dominic T. Moore, Paola A. Gehrig, Victoria Bae-Jump

International Journal of Gynecologic Cancer Feb 2016, 26 (2) 318-324; DOI: 10.1097/IGC.0000000000000596
Evaluation of TOP2A as a Predictive Marker for Endometrial Cancer With Taxane-Containing Adjuvant Chemotherapy
Fuminori Ito, Naoto Furukawa, Tokiko Nakai

International Journal of Gynecologic Cancer Feb 2016, 26 (2) 325-330; DOI: 10.1097/IGC.0000000000000607
Comparison of Serum Human Epididymis Protein 4 and Carbohydrate Antigen 125 as Markers in Endometrial Cancer: A Meta-Analysis
Lingli Hu, Shizheng Du, Wanhua Guo, Dezhu Chen, Ying Li

International Journal of Gynecologic Cancer Feb 2016, 26 (2) 331-340; DOI: 10.1097/IGC.0000000000000621
Survey of Current Practice Patterns in the Treatment of Early-Stage Endometrial Cancer
Elena B. Pereira, Brian De, Valentin Kolev, Konstantin Zakashansky, Sheryl Green, Peter Dottino, Vishal Gupta

International Journal of Gynecologic Cancer Feb 2016, 26 (2) 341-347; DOI: 10.1097/IGC.0000000000000589

Main menu

endometrial cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

endometrial cancer

Pages